Biju Nair sold $604k of AIZ
EVP at ASSURANT, INC.. 3,000 shares at an average of $201.50, traded Feb 19, 2025, filed Feb 20, 2025.
Score components
- +15RoleOfficer
- +19Trade size$604k at market
- +5Share of holdings soldSold 14% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-024264, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 19, 2025 | SOpen-market sale Common Stock | -1,870 | $201.27 | $376k | 18,838 | Feb 20, 2025 |
| Feb 19, 2025 | SOpen-market sale Common Stock | -1,130 | $201.87 | $228k | 17,708 | Feb 20, 2025 |
Related signals
Other insiders at ASSURANT, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 27Weak | AIZsell ASSURANT, INC. | Jay Rosenblum EVP and CLO | $202k 1,000 shares | -8% | |
| 49Moderate | ASSURANT, INC. | Robert Lonergan Chief Marketing & Risk Officer | $743k 3,500 shares | -12% | |
| 48Moderate | ASSURANT, INC. | Dimitry DiRienzo SVP, CAO, Controller | $352k 1,650 shares | -29% | |
| 40Moderate | AIZsell ASSURANT, INC. | Biju Nair EVP | $628k 3,000 shares | -13% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.